\-\ Texto\\:\\ \ \(0\)\
\-\ lipase\\ 90\\.\\ normal\\ ast\\,\\ alt\\,\\ alkphos\\,\\ amylase\\.\ \(0\)\
\-\ the\\ patient\\ was\\ not\\ a\\ candidate\\ for\\ surgery\\ and\\ decided\\ to\\ undergo\\ chemotherapy\\ for\\ treatment\\.\ \(0\)\
\-\ large\\ heterogeneously\\ hypoattenuating\\ pancreatic\\ head\\ mass\\ \ \(0\)\
\-\ encasing\\ the\\ smv\\,\\ splenic\\ vein\\,\\ and\\ a\\ portion\\ of\\ the\\ portal\\ vein\\.\ \(0\)\
\-\ pancreatic\\ adenocarcinoma\ \(3\)\
\-\ \\â\\€\\¢\\ pancreatic\\ adenocarcinoma\ \(0\)\
\-\ \\â\\€\\¢\\ chronic\\ \\ pancreatitis\ \(0\)\
\-\ \\â\\€\\¢\\ islet\\ cell\\ carcinoma\ \(0\)\
\-\ \\â\\€\\¢\\ metastases\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ 65\\ y\\/o\\ woman\\ with\\ abdominal\\ pain\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pancreatic\\:\\ 0\\.4305832450259227\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.2588066188510365\ \(0\)\
\-\ alkphos\\:\\ 0\\.23395557828033214\ \(0\)\
\-\ vein\\:\\ 0\\.2269687419395288\ \(0\)\
\-\ encasing\\:\\ 0\\.20346380983561982\ \(0\)\
\-\ smv\\:\\ 0\\.2012422401943152\ \(0\)\
\-\ islet\\:\\ 0\\.19727050436581436\ \(0\)\
\-\ hypoattenuating\\:\\ 0\\.18664062957525485\ \(0\)\
\-\ decided\\:\\ 0\\.18095660084775572\ \(0\)\
\-\ candidate\\:\\ 0\\.17297204139090747\ \(0\)\
\-\ amylase\\:\\ 0\\.16804053519059314\ \(0\)\
\-\ lipase\\:\\ 0\\.166778735921102\ \(0\)\
\-\ heterogeneously\\:\\ 0\\.16441519766474427\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.15700292247721093\ \(0\)\
\-\ splenic\\:\\ 0\\.15532029799763583\ \(0\)\
\-\ alt\\:\\ 0\\.15223325232567395\ \(0\)\
\-\ ast\\:\\ 0\\.1518704392674609\ \(0\)\
\-\ portal\\:\\ 0\\.15151230779882252\ \(0\)\
\-\ undergo\\:\\ 0\\.14785068473541213\ \(0\)\
\-\ 65\\:\\ 0\\.1354765506688941\ \(0\)\
\-\ metastases\\:\\ 0\\.1279957219849606\ \(0\)\
\-\ portion\\:\\ 0\\.11321446799617284\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.11242015867199608\ \(0\)\
\-\ for\\:\\ 0\\.09597327500679129\ \(0\)\
\-\ the\\:\\ 0\\.09477382462675306\ \(0\)\
\-\ carcinoma\\:\\ 0\\.09470196116309111\ \(0\)\
\-\ head\\:\\ 0\\.09442761161069732\ \(0\)\
\-\ lymphoma\\:\\ 0\\.094291447132876\ \(0\)\
\-\ chronic\\:\\ 0\\.09397630404539252\ \(0\)\
\-\ cell\\:\\ 0\\.0905683358536995\ \(0\)\
\-\ abdominal\\:\\ 0\\.08659132143946054\ \(0\)\
\-\ surgery\\:\\ 0\\.0851214095364975\ \(0\)\
\-\ woman\\:\\ 0\\.082455396004832\ \(0\)\
\-\ large\\:\\ 0\\.07932793221791291\ \(0\)\
\-\ treatment\\:\\ 0\\.07541788354803117\ \(0\)\
\-\ and\\:\\ 0\\.0654312254944416\ \(0\)\
\-\ normal\\:\\ 0\\.06464242309125934\ \(0\)\
\-\ not\\:\\ 0\\.06250235133446749\ \(0\)\
\-\ mass\\:\\ 0\\.06047535018490625\ \(0\)\
\-\ pain\\:\\ 0\\.05665397450055372\ \(0\)\
\-\ was\\:\\ 0\\.05517730692209613\ \(0\)\
\-\ patient\\:\\ 0\\.05149468624669355\ \(0\)\
\-\ to\\:\\ 0\\.03958056378694309\ \(0\)\
\-\ with\\:\\ 0\\.031001720465509284\ \(0\)\
\-\ of\\:\\ 0\\.030983208006108525\ \(0\)\
